Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | BioTech • FinTech (& Financials services) • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Pharmaceutical (& Medicine) |
Stages | Pre-Seed, Seed, Series A, Series B |
Investing | United States • Singapore • Europe • Asia |
Investment Range | $100,000 - $200,000 |
Investment Sweet Spot | $150,000 |
Assets Under Management | $400,000,000 |
Vertex Ventures HC is a venture capital fund specializing in healthcare investments with a focus on innovative life science sectors such as biopharmaceuticals, medical devices, and digital health. They actively seek to invest in healthcare visionaries developing novel therapeutic approaches that address significant unmet medical needs. With an investment range from $100,000 to $200,000 and a sweet spot of $150,000, they support companies in various development stages, from early, preclinical-stage companies to those seeking further growth at the commercial stage. Their goal is to build outstanding companies that enhance health and the quality of human life, with they playing an active role in their portfolio companies alongside entrepreneurs, industry partners, and fellow venture investors to create value for both shareholders and patients. VVHC is part of the Vertex global network of venture capital funds and holds offices in San Francisco and Boston. With over $400 million in assets under management, their investment team possesses deep local networks and the ability to act swiftly on investment opportunities across the U.S., Europe, Asia, and beyond. They pride themselves on their specialties in Pre-Seed, Seed, Series A, and Series B equity investments. The fund sustains a robust portfolio that includes companies with achievements such as FDA cleared products and clinical-stage assets, emphasizing their commitment to pushing the boundaries of medical innovation.